Phylogica Limited

ASX:PYC ISIN:AU000000PYC7

Phylogica Limited (Phylogica) is an Australia-based company principally engaged in the discovery and development of therapeutics directed at proteins and their interactions. The Company is engaged in the discovery of peptide-based drugs to treat inflammatory diseases.  
 
        

Lihat di Bahasa Lain

Berita

Laporan Pasar Australia 20 Desember 2010: IMX Resources (ASX:IXR) Meluncurkan Pengapalan Pertama Biji Tembaga Besinya ke Cina

🕔12/20/2010 1:30:00 PM 13437

Laporan Pasar Australia 20 Desember 2010 memuat: IMX Resources Limited (ASX:IXR) telah meluncurkan pengapalan pertamanya untuk biji tembaga besi ke Cina; Phylogica Limited (ASX:PYC) menanda tangani perjanjian kolaborasi danlisensi dengan Pfizer (NYSE:PFE); Copper Strike Limited (ASX:CSE) menerima hasil yang kuat untuk tembaga, perak, kobalt di Walford Creek, Queensland Baratlaut; Produksi biji besi South American Ferro Metals Limited (ASX:SFZ) di Brazil melampaui 400.000 ton.

Baca Full Story▸
###

89,366 TAMPILAN PROFIL PERUSAHAAN

  • Halaman ini dilihat: (7 Hari Terakhir: 45) (30 Hari Terakhir: 137) (Sejak Ditampilkan: 9377) 

Data Perusahaan

    Fax
  • 08 9423 8899 
    • Sektor Utama
  • Kesehatan & Pharm 
    • Industri Utama
  • Biotechnology 
    • Homepage
  • www.phylogica.com/

Lebih banyak Berita lagi

  • 2025/02/19: Completion of Institutional Entitlement Offer*
  • 2025/02/17: Cleansing Notice Under Section 708AA*
  • 2025/02/17: Proposed issue of securities - PYC*
  • 2025/02/17: PYC Equity Raising Presentation*
  • 2025/02/17: PYC Equity Raising to Raise up to $146 Million*
  • 2025/02/17: Trading Halt*
  • 2025/02/10: Approval to Commence Human Trials in Kidney Program*
  • 2025/02/03: Notification of cessation of securities - PYC*
  • 2025/01/31: ADOA Safety Review Committee Approves Dose Escalation*
  • 2025/01/29: Quarterly Activities/Appendix 4C Cash Flow Report*
*refer to company website